المؤلفون: Marcio Nucci, D Raghunadharao, Oliver A. Cornely, Luis Ostrosky-Zeichner, Sonja Koblinger, Antonio Freire, Andrew J. Ullmann, Amorn Leelarasamee, Johan Decruyenaere, Markus Ruhnke, Ploenchan Chetchotisakd, Heike Diekmann-Berndt, Ernst-Ruediger Kuse, V Ramasubramanian, Olivier Lortholary, Jagdev Singh Sekhon, Ignace Demeyer, Clovis Arns da Cunha, Didier Pittet, Carlos H. Barrios, Frédérique Jacobs

المصدر: The Lancet, Vol. 369, No 9572 (2007) pp. 1519-1527

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Antifungal Agents, Adolescent, Lipoproteins, Amphotericin B/ therapeutic use, Microbial Sensitivity Tests, Lipoproteins/ therapeutic use, Peptides, Cyclic, Echinocandins, Lipopeptides, chemistry.chemical_compound, Double-Blind Method, Amphotericin B, Internal medicine, Peptides, Cyclic/ therapeutic use, medicine, Humans, Adverse effect, Mycosis, Fungemia, Candidiasis/complications/ drug therapy/microbiology, APACHE, Aged, ddc:616, Aged, 80 and over, Voriconazole, business.industry, Antifungal Agents/ therapeutic use, Candidiasis, Micafungin, General Medicine, Middle Aged, bacterial infections and mycoses, medicine.disease, Apache, Surgery, Treatment Outcome, chemistry, Female, Caspofungin, business, Fluconazole, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c612bb7c29ee2d0d7e7effdc384368
https://doi.org/10.1016/s0140-6736(07)60605-9